Procter & Gamble Health Limited (PGHL) — Board Meeting | 26 June 2026

Procter & Gamble Health Limited announced a recommended final dividend of Rs. 45 per equity share for FY 2025-26, subject to shareholder approval at the upcoming AGM. The dividend will be paid to shareholders listed in the register as of the AGM record date. To comply with TDS provisions under Section 194 of the Income Tax Act, the company requires shareholders to update tax residential status, PAN, and contact details via depositories or its RTA, Kfin Technologies. Resident shareholders must submit Form 121 to claim NIL TDS if eligible, while non-resident shareholders must provide PAN, Tax Residency Certificate, Form 41, and a self-declaration to claim DTAA benefits. TDS rates apply at 20% (plus surcharge and cess) for non-residents unless a lower DTAA rate is approved. Shareholders must submit all documents by August 12, 2026, to avoid higher TDS deductions.